Allurion Technologies (ALUR) Change in Accured Expenses (2022 - 2026)
Allurion Technologies (ALUR) posted Change in Accured Expenses of -$1.4 million for Q1 2026, up 30.39% on a QoQ basis from -$2.0 million in Q4 2025, and up 7.15% year-over-year from -$1.3 million in Q1 2025.
Allurion Technologies (ALUR) Change in Accured Expenses (2022 - 2026) Analysis & Trends
Allurion Technologies' Change in Accured Expenses history runs 5 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- Quarterly Change in Accured Expenses rose 7.15% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.9 million (down 8.52% YoY) and the FY2025 annual result came in at -$5.0 million, down 23.86% from the prior year.
- Change in Accured Expenses was -$1.4 million for Q1 2026 at Allurion Technologies, up from -$2.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $3.7 million in Q4 2024 and bottomed at -$6.1 million in Q3 2024.
- A 5-year average of -$222333.3 and a median of -$724000.0 in 2024 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 196.91% in 2024, while the deepest fall reached 453.17% in 2024.
- Allurion Technologies' Change in Accured Expenses stood at $2.5 million in 2022, then plunged by 254.05% to -$3.8 million in 2023, then jumped by 196.91% to $3.7 million in 2024, then tumbled by 152.86% to -$2.0 million in 2025, then surged by 30.39% to -$1.4 million in 2026.
- Business Quant data shows ALUR's Change in Accured Expenses at -$1.4 million in Q1 2026, -$2.0 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | -1.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.36 Mn |
| Mar 31, 2026 | -1.36 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Dec 31, 2025 | -1.96 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Sep 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | -2.76 Mn |
| Jun 30, 2025 | -2.76 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Mar 31, 2025 | -1.47 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | -6.06 Mn |
| Sep 30, 2024 | -6.06 Mn |
| Jun 30, 2024 | -724,000.00 |
| Jun 30, 2024 | -724,000.00 |
| Mar 31, 2024 | -989,000.00 |
| Mar 31, 2024 | -989,000.00 |
| Dec 31, 2023 | -3.82 Mn |
| Dec 31, 2023 | -3.82 Mn |